Benzenamine, 3-chloro-4-fluoro-N-methyl-, hydrochloride (1:1), 1g

5-Bromo-6-hydroxy-2-methylpyrimidin-4(1H)-one, 95.0%, 250mg

3-(2-chloroethyl)-5-(methoxymethyl)-1,2,4-oxadiazole, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 10 m, 0.53 mm, 1.00 µm, 1 Piece(s)

N-(4-fluorophenyl)-N-isopropyl-2-((5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy)acetamide, 98%, 1g

(4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)DIHYDROFURAN-2(3H)-ONE, 95.0%, 500g

3,4-Diethoxy-benzylamine, 250mg

1-(2-CHLOROPHENYL)CYCLOPROPANECARBONITRILE, 95.0%, 1g

5-Bromo-1H-indene, 95.0%, 1g

3-Bromotetrahydrofuran, 96.0%, 5g

Acetic acid isobutyl ester, min. 99%, for synthesis, 1 l, glass packaging

ETHYL 2-METHYL-2,4,6,7-TETRAHYDROPYRANO[4,3-C]PYRAZOLE-3-CARBOXYLATE, 95.0%, 250mg

3-BOC-3-AZABICYCLO[3.1.0]HEXANE-1-CARBOXYLIC ACID, 95.0%, 1g